Inozyme Pharma (INZY) Short Interest Ratio & Short Volume → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free INZY Stock Alerts $4.41 +0.08 (+1.85%) (As of 03:34 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Inozyme Pharma Short Interest DataCurrent Short Volume3,150,000 sharesPrevious Short Volume2,580,000 sharesChange Vs. Previous Month+22.09%Dollar Volume Sold Short$14.84 millionShort Interest Ratio / Days to Cover4.7Last Record DateApril 15, 2024Outstanding Shares61,770,000 sharesFloat Size41,140,000 sharesShort Percent of Float7.66%Today's Trading Volume426,702 sharesAverage Trading Volume616,111 sharesToday's Volume Vs. Average69% Short Selling Inozyme Pharma ? Sign up to receive the latest short interest report for Inozyme Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINZY Short Interest Over TimeINZY Days to Cover Over TimeINZY Percentage of Float Shorted Over Time Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. Inozyme Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,150,000 shares $14.84 million +22.1%7.7%4.7 $4.71 3/31/20242,580,000 shares $19.76 million +8.4%6.3%4.2 $7.66 3/15/20242,380,000 shares $14.02 million +2.6%5.8%4.6 $5.89 2/29/20242,320,000 shares $14.76 million -3.3%5.6%4.8 $6.36 2/15/20242,400,000 shares $13.70 million -16.4%5.8%5.4 $5.71 1/31/20242,870,000 shares $15.79 million +4.7%6.8%6.9 $5.50 Get the Latest News and Ratings for INZY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inozyme Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,740,000 shares $11.54 million -10.8%6.5%6.7 $4.21 12/31/20233,070,000 shares $13.08 million +91.9%7.2%7.6 $4.26 12/15/20231,600,000 shares $6.43 million -28.6%3.8%3.7 $4.02 11/30/20232,240,000 shares $8.62 million -0.4%5.3%4.5 $3.85 11/15/20232,250,000 shares $7.20 million +8.2%5.3%4.2 $3.20 10/31/20232,080,000 shares $6.18 million -15.5%4.7%3.6 $2.97 10/15/20232,460,000 shares $8.35 million +6.5%5.5%3.7 $3.40 9/30/20232,310,000 shares $9.70 million +12.7%5.2%3.3 $4.20 9/15/20232,050,000 shares $8.82 million +21.3%4.6%3 $4.30 8/31/20231,690,000 shares $8.28 million -17.2%4.5%2.6 $4.90 8/15/20232,040,000 shares $9.83 million +11.5%5.4%3.3 $4.82 7/31/20231,830,000 shares $9.33 million +7.7%4.0%2.8 $5.10 7/15/20231,700,000 shares $10.35 million +37.1%4.9%3.1 $6.09 6/30/20231,240,000 shares $6.91 million +248.1%3.5%2 $5.57 6/15/2023356,200 shares $2.07 million +24.9%1.0%0.5 $5.81 5/31/2023285,100 shares $1.71 million -53.0%0.8%0.4 $5.99 5/15/2023606,300 shares $3.93 million No Change1.7%0.7 $6.49 10/31/2022166,500 shares $293,040.00 -4.8%N/A2.3 $1.76 10/15/2022174,800 shares $457,976.00 -4.4%N/A2.9 $2.62 9/30/2022182,900 shares $490,172.00 No ChangeN/A2.4 $2.68 9/15/2022182,900 shares $610,886.00 -7.6%0.8%1.5 $3.34 8/31/2022197,900 shares $593,700.00 -25.9%0.9%1.2 $3.00 8/15/2022267,000 shares $1.00 million -18.8%1.2%1.5 $3.76 7/31/2022328,800 shares $1.21 million -26.3%N/A1.7 $3.69 7/15/2022446,200 shares $2.23 million -47.1%N/A1.8 $5.00 6/30/2022842,900 shares $4.02 million -2.5%N/A2.8 $4.77 6/15/2022864,400 shares $4.02 million +0.3%N/A2.8 $4.65 5/31/2022861,600 shares $3.18 million +13.8%N/A3.5 $3.69 5/15/2022757,200 shares $3.20 million -13.6%N/A3.4 $4.23 4/30/2022876,200 shares $3.46 million +118.3%N/A4.2 $3.95 4/15/2022401,300 shares $1.71 million +23.5%1.7%2.3 $4.26 3/31/2022325,000 shares $1.33 million +12.2%N/A3.7 $4.09 3/15/2022289,700 shares $1.17 million -3.9%2.1%4.4 $4.03 2/28/2022301,300 shares $1.74 million +9.7%2.2%4.5 $5.77Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. INZY Short Interest - Frequently Asked Questions What is Inozyme Pharma's current short interest? Short interest is the volume of Inozyme Pharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 3,150,000 shares of INZY short. 7.66% of Inozyme Pharma's shares are currently sold short. Learn More on Inozyme Pharma's current short interest. What is a good short interest ratio for Inozyme Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INZY shares currently have a short interest ratio of 5.0. Learn More on Inozyme Pharma's short interest ratio. What is a good short interest percentage for Inozyme Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.66% of Inozyme Pharma's floating shares are currently sold short. Is Inozyme Pharma's short interest increasing or decreasing? Inozyme Pharma saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 3,150,000 shares, an increase of 22.1% from the previous total of 2,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Inozyme Pharma's float size? Inozyme Pharma currently has issued a total of 61,770,000 shares. Some of Inozyme Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Inozyme Pharma currently has a public float of 41,140,000 shares. How does Inozyme Pharma's short interest compare to its competitors? 7.66% of Inozyme Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Inozyme Pharma: Nanobiotix S.A. (0.11%), Vanda Pharmaceuticals Inc. (3.80%), Enanta Pharmaceuticals, Inc. (13.94%), RAPT Therapeutics, Inc. (9.14%), Werewolf Therapeutics, Inc. (1.40%), Pyxis Oncology, Inc. (4.78%), Nektar Therapeutics (1.75%), ESSA Pharma Inc. (1.74%), Akebia Therapeutics, Inc. (6.54%), Renovaro Inc. (2.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Inozyme Pharma stock? Short selling INZY is an investing strategy that aims to generate trading profit from Inozyme Pharma as its price is falling. INZY shares are trading up $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Inozyme Pharma? A short squeeze for Inozyme Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INZY, which in turn drives the price of the stock up even further. How often is Inozyme Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INZY, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NBTX Short Interest Data VNDA Short Interest Data ENTA Short Interest Data RAPT Short Interest Data HOWL Short Interest Data PYXS Short Interest Data NKTR Short Interest Data EPIX Short Interest Data AKBA Short Interest Data RENB Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INZY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold